FDA Commissioner Tukaram Mundhe said confusion caused by similar brand names, which could lead doctors, pharmacists or patients to administer the wrong drug, amounted to a serious public health concern.
FDA Commissioner Tukaram Mundhe said confusion caused by similar brand names, which could lead doctors, pharmacists or patients to administer the wrong drug, amounted to a serious public health concern.
<iframe src="https://hindustansphere.com/embed/cluster/4105ac441ec6571205efbf77e0cac3aeea01f394" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Maharashtra FDA Acts Against Cadila Pharma; Bars Sale Of Two Sets Of Medicines Over Brand Confusion"></iframe>
